# CVE-2023-26217: TIBCO EBX Add-ons SQL Injection Vulnerability

> A low-privileged user with import permissions can execute arbitrary SQL statements on the TIBCO EBX server via the Data Exchange Add-on.

- **Severity:** High 8.8 (`CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H`)
- **Exploited in the wild:** Not known
- **Login needed:** Any signed-in user
- **Attackable:** Over the internet
- **Victim action needed:** Not needed
- **Fix available:** No
- **Published:** 19 Jul 2023
- **Updated:** 24 Oct 2024
- **Also known as:** GHSA-6hvj-j96w-8755

## What is CVE-2023-26217?

CVE-2023-26217 is a high-severity SQL injection vulnerability in TIBCO EBX Add-ons, published on 19 Jul 2023. Any signed-in user can exploit it over the network, with no action from the victim.

### Official description

The Data Exchange Add-on component of TIBCO Software Inc.'s TIBCO EBX Add-ons contains an easily exploitable vulnerability that allows a low privileged user with import permissions and network access to the EBX server to execute arbitrary SQL statements on the affected system. Affected releases are TIBCO Software Inc.'s TIBCO EBX Add-ons: versions 4.5.17 and below, versions 5.6.2 and below, version 6.1.0.

Weakness: CWE-89 (Improper Neutralization of Special Elements used in an SQL Command)

## Which versions are affected by CVE-2023-26217?

It affects 1 product.


Products: Tibco Ebx Add-Ons.

## How do I fix CVE-2023-26217?

No fix has been published for CVE-2023-26217 yet. Limit exposure of the affected software until one is available.

## Is CVE-2023-26217 being exploited?

There is no known exploitation of CVE-2023-26217 in the wild and no public exploit code.

## Other vulnerabilities in TIBCO EBX Add-ons

- [CVE-2023-26216](https://insights.sbomify.com/CVE-2023-26216/): TIBCO EBX Add-ons Arbitrary File Write (critical 9.1)
- [CVE-2022-41566](https://insights.sbomify.com/CVE-2022-41566/): TIBCO EBX Add-ons Cross Site Scripting (XSS) Vulnerability (high 8.7)
- [CVE-2022-30578](https://insights.sbomify.com/CVE-2022-30578/): TIBCO EBX Add-ons Stored XSS vulnerability (high 8.0)
- [CVE-2023-26215](https://insights.sbomify.com/CVE-2023-26215/): TIBCO EBX® Add-ons Path Traversal (high 7.7)
- [CVE-2019-17331](https://insights.sbomify.com/CVE-2019-17331/): TIBCO EBX Add-on For Data Exchange Cross-Site Scripting Vulnerabilities (high 7.3)

## Fix prompt for AI coding agents

```text
Check this codebase for CVE-2023-26217 and fix it if it is affected.

What it is: CVE-2023-26217 is a high-severity SQL injection vulnerability in TIBCO EBX Add-ons, published on 19 Jul 2023. Any signed-in user can exploit it over the network, with no action from the victim.
Exploitation: There is no known exploitation of CVE-2023-26217 in the wild and no public exploit code.

Affected product: TIBCO EBX Add-ons. No package-level version data is available, so check the vendor advisory linked from the reference page.

Task:
1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.
2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.
3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.
4. Run the tests and summarise what changed and why.
5. If nothing in the project is affected, say so and change nothing.

Reference: https://insights.sbomify.com/CVE-2023-26217/ (Markdown: https://insights.sbomify.com/CVE-2023-26217/index.md)
```

## Sources

- CVE record: https://www.cve.org/CVERecord?id=CVE-2023-26217
- NVD: https://nvd.nist.gov/vuln/detail/CVE-2023-26217
- OSV: https://osv.dev/vulnerability/CVE-2023-26217

---
From sbomify Insights: https://insights.sbomify.com/CVE-2023-26217/
Summaries are generated and may contain mistakes; the official description above is the record.